Southern Co. (SO) Financials Nov 14, 2014, 5:19
Southern Co. (SO) Financials Nov 14, 2014, 5:19 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Southern Co.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 15.74B 17.46B 17.66B 16.54B 17.09B
Cost of Goods Sold (COGS) incl. D&A 11.63B 12.79B 12.48B 11.39B 11.78B
COGS excluding D&A 9.85B 10.96B 10.43B 9.24B 9.48B
Depreciation & Amortization Expense 1.79B 1.83B 2.05B 2.15B 2.3B
Depreciation - - - - -
Amortization of Intangibles - - - - -
Gross Income 4.1B 4.67B 5.18B 5.15B 5.31B
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 0 0 0 0 0
Research & Development 0 0 0 0 0
Other SG&A 0 0 0 0 0
Other Operating Expense 818M 869M 901M 914M 934M
Unusual Expense 376M 196M 227M (28M) 0
EBIT after Unusual Expense (376M) (196M) (227M) 28M 0
Non Operating Income/Expense 531M 309M 278M 282M (1.01B)
Non-Operating Interest Income 23M 24M 0 40M 19M
Equity in Affiliates (Pretax) (1M) - - 0 0
Interest Expense 859M 870M 843M 838M 824M
Gross Interest Expense 943M 956M 921M 921M 916M
Interest Capitalized 84M 86M 78M 83M 92M
Pretax Income 2.6B 3.07B 3.49B 3.75B 2.56B
Income Tax 896M 1.03B 1.22B 1.33B 849M
Income Tax - Current Domestic 871M (12M) 65M 238M 353M
Income Tax - Current Foreign - - - - -
Income Tax - Deferred Domestic 25M 1.04B 1.15B 1.1B 496M
Income Tax - Deferred Foreign - - - - -
Income Tax Credits - - - 0 0
Equity in Affiliates - - - 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 1.71B 2.04B 2.27B 2.42B 1.71B
Minority Interest Expense 0 0 0 0 0
Net Income 1.71B 2.04B 2.27B 2.42B 1.71B
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 1.71B 2.04B 2.27B 2.42B 1.71B
Preferred Dividends 65M 65M 65M 65M 66M
Net Income Available to Common 1.64B 1.98B 2.2B 2.35B 1.64B
EPS (Basic) 2.07 2.37 2.57 2.70 1.88
Basic Shares Outstanding 795M 832M 857M 871M 877M
EPS (Diluted) 2.06 2.36 2.55 2.67 1.87
Diluted Shares Outstanding 796M 837M 864M 879M 881M
EBITDA 5.07B 5.63B 6.33B 6.38B 6.67B
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...
Continue Reading
Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...
Continue Reading
First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...
Continue Reading
A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...
Continue Reading
A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...
Continue Reading
A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...
Continue Reading
Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...
Continue Reading
Top 5 Most Recently Viewed Articles
KPN Achieves Remarkable Growth in Q2 2025 KPN has recently demonstrated a strong performance in the second quarter of 2025, showcasing impressive growth across various segments. The company reported a year-on-year growth of 3.7% in service revenues, a testament to its robust business strategy and market position. Consumer Service Revenue Gains The consumer segment has...
Continue Reading
Socket Mobile Reports Q3 Financial Results Socket Mobile, Inc. (NASDAQ: SCKT), a prominent name in the field of data capture and delivery solutions, recently disclosed its financial results for the third quarter of 2024, presenting notable shifts in revenue and product adoption. The company emphasizes its commitment to enhancing productivity through innovative...
Continue Reading
Sapiens UnderwritingPro Achieves Recognition for Excellence Sapiens International Corporation has once again made waves in the insurance industry with its advanced UnderwritingPro solution. Renowned for driving efficiency and automation, the software provides comprehensive functionality that benefits insurers across various sectors. Honored with the XCelent Award...
Continue Reading
Investing in Luminar Technologies: What You Need to Know For those invested in Luminar Technologies, Inc. (NASDAQ: LAZR), important news is unfolding regarding a recent class-action lawsuit that has potential implications for shareholders. The Rosen Law Firm, a reputable entity in securities law, has issued a reminder for investors who purchased Luminar securities during...
Continue Reading
Recognizing the Unsung Heroes of Home Comfort Let's face it, HVAC techs don't always get the recognition they deserve. On National HVAC Technician Day, June 22, Bacon Plumbing Heating Air Electric took a moment to shine a light on those skilled folks keeping homes comfy year-round across the Dallas-Fort Worth Metroplex. You know, the folks who swoop in just in time during...
Continue Reading